MA54378A - Composés hétéroaromatiques utilisés en tant qu'inhibiteurs de vanine - Google Patents
Composés hétéroaromatiques utilisés en tant qu'inhibiteurs de vanineInfo
- Publication number
- MA54378A MA54378A MA054378A MA54378A MA54378A MA 54378 A MA54378 A MA 54378A MA 054378 A MA054378 A MA 054378A MA 54378 A MA54378 A MA 54378A MA 54378 A MA54378 A MA 54378A
- Authority
- MA
- Morocco
- Prior art keywords
- compounds used
- heteroaromatic compounds
- vanin
- inhibitors
- vanin inhibitors
- Prior art date
Links
- 150000002390 heteroarenes Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18209721 | 2018-12-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA54378A true MA54378A (fr) | 2022-03-09 |
Family
ID=64572152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA054378A MA54378A (fr) | 2018-12-03 | 2019-12-02 | Composés hétéroaromatiques utilisés en tant qu'inhibiteurs de vanine |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US11078182B2 (fr) |
| EP (1) | EP3891139A1 (fr) |
| JP (2) | JP7130873B2 (fr) |
| KR (1) | KR20210100150A (fr) |
| CN (2) | CN114478485B (fr) |
| AR (1) | AR117229A1 (fr) |
| AU (1) | AU2019391279B2 (fr) |
| BR (1) | BR112021007915A2 (fr) |
| CA (1) | CA3116830A1 (fr) |
| CL (2) | CL2021001198A1 (fr) |
| CO (1) | CO2021007173A2 (fr) |
| CR (1) | CR20210294A (fr) |
| DO (1) | DOP2021000071A (fr) |
| EA (1) | EA202191476A1 (fr) |
| EC (1) | ECSP21040278A (fr) |
| IL (1) | IL283397B2 (fr) |
| JO (2) | JOP20210127A1 (fr) |
| MA (1) | MA54378A (fr) |
| MX (1) | MX2021006520A (fr) |
| PE (1) | PE20211769A1 (fr) |
| PH (1) | PH12021551280A1 (fr) |
| SA (1) | SA521422152B1 (fr) |
| SG (1) | SG11202104437XA (fr) |
| TW (1) | TWI838430B (fr) |
| UA (1) | UA128374C2 (fr) |
| WO (1) | WO2020114943A1 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019326933B2 (en) | 2018-08-28 | 2024-12-05 | Boehringer Ingelheim International Gmbh | Heteroaromatic compounds as Vanin inhibitors |
| US12037354B2 (en) | 2018-11-30 | 2024-07-16 | Vectivbio Comet Ag | Cyclic pantetheine derivatives and uses thereof |
| MX2021006489A (es) * | 2018-12-03 | 2021-07-06 | Boehringer Ingelheim Int | Compuestos heteroaromaticos como inhibidores de vanina. |
| IL283397B2 (en) * | 2018-12-03 | 2025-03-01 | Boehringer Ingelheim Int | Heteroaromatic compounds as vanin inhibitors |
| EA202191477A1 (ru) | 2018-12-03 | 2021-10-13 | Бёрингер Ингельхайм Интернациональ Гмбх | Гетероароматические соединения в качестве ингибиторов ванина |
| US20230107927A1 (en) | 2020-02-28 | 2023-04-06 | First Wave Bio, Inc. | Methods of treating iatrogenic autoimmune colitis |
| US20250197414A1 (en) * | 2022-03-18 | 2025-06-19 | Shanghai Meiyue Biotech Development Co., Ltd. | Salt form and crystal form of vanin enzyme inhibitor, method for preparing same, and use thereof |
| CN121175307A (zh) * | 2023-03-21 | 2025-12-19 | 阿索斯治疗公司 | Vanin-1抑制剂 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030195192A1 (en) * | 2002-04-05 | 2003-10-16 | Fortuna Haviv | Nicotinamides having antiangiogenic activity |
| DE602004018811D1 (de) | 2003-10-09 | 2009-02-12 | Abbott Lab | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren |
| US9585891B2 (en) | 2012-09-25 | 2017-03-07 | Merck Patent Gmbh | Alpha hydroxy amides |
| JP2018516254A (ja) | 2015-05-29 | 2018-06-21 | ファイザー・インク | バニン1酵素の阻害薬としての新規なヘテロ環化合物 |
| EP3484876A1 (fr) | 2016-07-14 | 2019-05-22 | Pfizer Inc | Nouveaux pyrimidine carboxamides utilisées comme inhibiteurs de l'enzyme vanin-1 |
| AU2018285131B2 (en) | 2017-06-12 | 2021-11-11 | Boehringer Ingelheim International Gmbh | Heteroaromatic compounds as Vanin inhibitors |
| AU2019326933B2 (en) | 2018-08-28 | 2024-12-05 | Boehringer Ingelheim International Gmbh | Heteroaromatic compounds as Vanin inhibitors |
| MX2021006489A (es) * | 2018-12-03 | 2021-07-06 | Boehringer Ingelheim Int | Compuestos heteroaromaticos como inhibidores de vanina. |
| IL283397B2 (en) * | 2018-12-03 | 2025-03-01 | Boehringer Ingelheim Int | Heteroaromatic compounds as vanin inhibitors |
| EA202191477A1 (ru) * | 2018-12-03 | 2021-10-13 | Бёрингер Ингельхайм Интернациональ Гмбх | Гетероароматические соединения в качестве ингибиторов ванина |
-
2019
- 2019-12-02 IL IL283397A patent/IL283397B2/en unknown
- 2019-12-02 WO PCT/EP2019/083252 patent/WO2020114943A1/fr not_active Ceased
- 2019-12-02 MX MX2021006520A patent/MX2021006520A/es unknown
- 2019-12-02 BR BR112021007915-7A patent/BR112021007915A2/pt unknown
- 2019-12-02 UA UAA202103638A patent/UA128374C2/uk unknown
- 2019-12-02 CR CR20210294A patent/CR20210294A/es unknown
- 2019-12-02 SG SG11202104437XA patent/SG11202104437XA/en unknown
- 2019-12-02 AR ARP190103518A patent/AR117229A1/es not_active Application Discontinuation
- 2019-12-02 CN CN202210061725.6A patent/CN114478485B/zh active Active
- 2019-12-02 TW TW108143868A patent/TWI838430B/zh active
- 2019-12-02 PE PE2021000809A patent/PE20211769A1/es unknown
- 2019-12-02 JO JOP/2021/0127A patent/JOP20210127A1/ar unknown
- 2019-12-02 EP EP19817182.9A patent/EP3891139A1/fr active Pending
- 2019-12-02 JP JP2021531556A patent/JP7130873B2/ja active Active
- 2019-12-02 MA MA054378A patent/MA54378A/fr unknown
- 2019-12-02 AU AU2019391279A patent/AU2019391279B2/en active Active
- 2019-12-02 JO JOP/2021/0128A patent/JOP20210128A1/ar unknown
- 2019-12-02 US US16/699,799 patent/US11078182B2/en active Active
- 2019-12-02 KR KR1020217020910A patent/KR20210100150A/ko active Pending
- 2019-12-02 CA CA3116830A patent/CA3116830A1/fr active Pending
- 2019-12-02 CN CN201980078414.7A patent/CN113166104A/zh active Pending
- 2019-12-02 EA EA202191476A patent/EA202191476A1/ru unknown
-
2021
- 2021-04-16 DO DO2021000071A patent/DOP2021000071A/es unknown
- 2021-05-06 CL CL2021001198A patent/CL2021001198A1/es unknown
- 2021-05-31 CO CONC2021/0007173A patent/CO2021007173A2/es unknown
- 2021-06-01 SA SA521422152A patent/SA521422152B1/ar unknown
- 2021-06-01 PH PH12021551280A patent/PH12021551280A1/en unknown
- 2021-06-03 EC ECSENADI202140278A patent/ECSP21040278A/es unknown
- 2021-06-25 US US17/358,111 patent/US20220048885A1/en not_active Abandoned
- 2021-12-30 CL CL2021003568A patent/CL2021003568A1/es unknown
-
2022
- 2022-08-24 JP JP2022133354A patent/JP2022188014A/ja not_active Withdrawn
- 2022-11-02 US US18/051,953 patent/US20230295112A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA54378A (fr) | Composés hétéroaromatiques utilisés en tant qu'inhibiteurs de vanine | |
| MA52486A (fr) | Pyridazinones utilisés en tant qu'inhibiteurs de parp7 | |
| MA54076A (fr) | 2-amino-n-hétéroaryl-nicotinamides utilisés en tant qu'inhibiteurs de nav1.8 | |
| EP3873468A4 (fr) | 2-amino-n-phényl-nicotinamides utilisés en tant qu'inhibiteurs de nav1.8 | |
| MA43169A (fr) | Composés hétérocycliques utilisés en tant qu'inhibiteurs de pi3k-gamma | |
| MA51846A (fr) | Composés hétérocycliques utilisés en tant qu'inhibiteurs de kinases | |
| MA49374A (fr) | Composés hétéroaromatiques utilisés en tant qu'inhibiteurs de vanine | |
| MA49888A (fr) | Composés macrocycliques utilisés en tant qu'inhibiteurs de kinase ros1 | |
| MA51438A (fr) | Composés hétérocycliques utilisés en tant qu'inhibiteurs de lsd1 | |
| MA52189A (fr) | Benzothiophènes et composés associés utilisés en tant qu'agonistes de sting | |
| MA47099A (fr) | Composés hétéroaromatiques bicycliques utilisés en tant qu'immunomodulateurs | |
| MA56398A (fr) | Composés 2,3-dihydroquinazoline en tant qu'inhibiteurs de nav1.8 | |
| MA45375A (fr) | Composés hétérocycliques utilisés en tant qu'agents antibacteriens | |
| MA47013A (fr) | Composés benzolactames utilisés en tant qu'inhibiteurs de protéine kinase | |
| MA45377A (fr) | Composés hétérocycliques en tant qu'agents antibacteriens | |
| EP3621624A4 (fr) | Composés dinucléotidiques cycliques en tant qu'agonistes sting | |
| MA53377A (fr) | Composés de pyridin-2-one utiles en tant qu'antagonistes de smarca2 | |
| MA49566A (fr) | Carboxamides utilisés en tant qu'inhibiteurs des canaux sodiques | |
| MA51878A (fr) | Composés d'aminothiazole en tant qu'inhibiteurs de c-kit | |
| MA49956A (fr) | Composés de pyrimidine utilisés en tant qu'inhibiteurs de kinase jak | |
| MA51431A (fr) | Dérivés d'oxy-fluoropipéridine utilisés en tant qu'inhibiteur de kinase | |
| EP3442488A4 (fr) | Compositions pour l'application topique de composés | |
| EP3733671A4 (fr) | Dérivés amino-fluoropipéridines utilisés en tant qu'inhibiteur de kinase | |
| EP3442973A4 (fr) | Nouveaux composés utilisés en tant qu'inhibiteurs de l'autotaxine et compositions pharmaceutiques les comprenant | |
| MA42919A (fr) | Composés bicycliques utilisés en tant qu'inhibiteurs d'atx |